93 related articles for article (PubMed ID: 32679228)
1. Lysosome Associated Protein Transmembrane 4B-24 Is the Predominant Protein Isoform in Human Tissues and Undergoes Rapid, Nutrient-Regulated Turnover.
Zhou K; Dichlberger A; Ikonen E; Blom T
Am J Pathol; 2020 Oct; 190(10):2018-2028. PubMed ID: 32679228
[TBL] [Abstract][Full Text] [Related]
2. Lysosomal-associated transmembrane protein 4B regulates ceramide-induced exosome release.
Yuyama K; Sun H; Mikami D; Mioka T; Mukai K; Igarashi Y
FASEB J; 2020 Dec; 34(12):16022-16033. PubMed ID: 33090522
[TBL] [Abstract][Full Text] [Related]
3. LAPTM4B facilitates late endosomal ceramide export to control cell death pathways.
Blom T; Li S; Dichlberger A; Bäck N; Kim YA; Loizides-Mangold U; Riezman H; Bittman R; Ikonen E
Nat Chem Biol; 2015 Oct; 11(10):799-806. PubMed ID: 26280656
[TBL] [Abstract][Full Text] [Related]
4. LAPTM4B-35 promotes cancer cell migration via stimulating integrin beta1 recycling and focal adhesion dynamics.
Liu M; Yan R; Wang J; Yao Z; Fan X; Zhou K
Cancer Sci; 2022 Jun; 113(6):2022-2033. PubMed ID: 35381120
[TBL] [Abstract][Full Text] [Related]
5. LAPTM4B is a PtdIns(4,5)P2 effector that regulates EGFR signaling, lysosomal sorting, and degradation.
Tan X; Sun Y; Thapa N; Liao Y; Hedman AC; Anderson RA
EMBO J; 2015 Feb; 34(4):475-90. PubMed ID: 25588945
[TBL] [Abstract][Full Text] [Related]
6. Lysosomal transmembrane protein LAPTM4B promotes autophagy and tolerance to metabolic stress in cancer cells.
Li Y; Zhang Q; Tian R; Wang Q; Zhao JJ; Iglehart JD; Wang ZC; Richardson AL
Cancer Res; 2011 Dec; 71(24):7481-9. PubMed ID: 22037872
[TBL] [Abstract][Full Text] [Related]
7. Expression of lysosome-associated protein transmembrane 4B-35 in cancer and its correlation with the differentiation status of hepatocellular carcinoma.
Peng C; Zhou RL; Shao GZ; Rui JA; Wang SB; Lin M; Zhang S; Gao ZF
World J Gastroenterol; 2005 May; 11(18):2704-8. PubMed ID: 15884107
[TBL] [Abstract][Full Text] [Related]
8. Correlation of lysosome-associated protein transmembrane-4β gene overexpression with the malignant phenotypes of hepatocellular carcinoma.
Su H; Xu T; Huang X; Zang S; Wang B; Huang Y; Liu J; Huang A
Pathol Res Pract; 2017 Dec; 213(12):1536-1541. PubMed ID: 29108920
[TBL] [Abstract][Full Text] [Related]
9. Structure analysis and expressions of a novel tetratransmembrane protein, lysosoma-associated protein transmembrane 4 beta associated with hepatocellular carcinoma.
Liu XR; Zhou RL; Zhang QY; Zhang Y; Jin YY; Lin M; Rui JA; Ye DX
World J Gastroenterol; 2004 Jun; 10(11):1555-9. PubMed ID: 15162524
[TBL] [Abstract][Full Text] [Related]
10. LAPTM4B controls the sphingolipid and ether lipid signature of small extracellular vesicles.
Dichlberger A; Zhou K; Bäck N; Nyholm T; Backman A; Mattjus P; Ikonen E; Blom T
Biochim Biophys Acta Mol Cell Biol Lipids; 2021 Feb; 1866(2):158855. PubMed ID: 33181324
[TBL] [Abstract][Full Text] [Related]
11. LAPTM4B: a novel cancer-associated gene motivates multidrug resistance through efflux and activating PI3K/AKT signaling.
Li L; Wei XH; Pan YP; Li HC; Yang H; He QH; Pang Y; Shan Y; Xiong FX; Shao GZ; Zhou RL
Oncogene; 2010 Oct; 29(43):5785-95. PubMed ID: 20711237
[TBL] [Abstract][Full Text] [Related]
12. LAPTM4B down regulation inhibits the proliferation, invasion and angiogenesis of HeLa cells in vitro.
Meng F; Chen X; Song H; Lou G
Cell Physiol Biochem; 2015; 37(3):890-900. PubMed ID: 26383850
[TBL] [Abstract][Full Text] [Related]
13. Differential expression of lysosome-associated protein transmembrane-4 beta (LAPTM4B) in granulosa cells of ovarian follicles and in other bovine tissues.
Ndiaye K; Carrière PD; Sirois J; Silversides DW; Lussier JG
J Ovarian Res; 2015 Mar; 8():12. PubMed ID: 25881887
[TBL] [Abstract][Full Text] [Related]
14. The Transcription Factor AP4 Promotes Oncogenic Phenotypes and Cisplatin Resistance by Regulating
Wang L; Meng Y; Xu JJ; Zhang QY
Mol Cancer Res; 2018 May; 16(5):857-868. PubMed ID: 29378908
[TBL] [Abstract][Full Text] [Related]
15. Upregulation of LAPTM4B-35 promotes malignant transformation and tumorigenesis in L02 human liver cell line.
Li L; Shan Y; Yang H; Zhang S; Lin M; Zhu P; Chen XY; Yi J; McNutt MA; Shao GZ; Zhou RL
Anat Rec (Hoboken); 2011 Jul; 294(7):1135-42. PubMed ID: 21618708
[TBL] [Abstract][Full Text] [Related]
16. Lentivirus-mediated RNA Interference Targeting LAPTM4B Inhibits Human Ovarian Cancer Cell Invasion In Vitro.
Meng F; Chen X; Song H; Lou G; Fu S
Chem Biol Drug Des; 2016 Jan; 87(1):121-30. PubMed ID: 26247403
[TBL] [Abstract][Full Text] [Related]
17. LAPTM4b recruits the LAT1-4F2hc Leu transporter to lysosomes and promotes mTORC1 activation.
Milkereit R; Persaud A; Vanoaica L; Guetg A; Verrey F; Rotin D
Nat Commun; 2015 May; 6():7250. PubMed ID: 25998567
[TBL] [Abstract][Full Text] [Related]
18. AP4 positively regulates LAPTM4B to promote hepatocellular carcinoma growth and metastasis, while reducing chemotherapy sensitivity.
Meng Y; Wang L; Xu J; Zhang Q
Mol Oncol; 2018 Mar; 12(3):373-390. PubMed ID: 29337428
[TBL] [Abstract][Full Text] [Related]
19. LAPTM4B promotes AML progression through regulating RPS9/STAT3 axis.
Huang Y; Peng M; Qin H; Li Y; Pei L; Liu X; Zhao X
Cell Signal; 2023 Jun; 106():110623. PubMed ID: 36758682
[TBL] [Abstract][Full Text] [Related]
20. Lysosomal-associated protein transmembrane 4 Beta-35 overexpression is a novel independent prognostic marker for gastric carcinoma.
Liu L; Xu X; Jing L; Zhou G; Cao Z; Han Y; Zhou R
PLoS One; 2015; 10(2):e0118026. PubMed ID: 25689860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
